期刊文献+

洛汀新对轻中度高血压降压效果及安全性分析

Analysis of Efficacy and Security of Lotensin for Hypertension
下载PDF
导出
摘要 目的 :观察洛汀新对轻中度高血压的降压效果及安全性。方法 :选择原发性高血压病人 5 8例经洛汀新治疗。结果 :治疗 8周后 ,血压由治疗前的 ( 14 3 .7± 18.7) / ( 92 .2± 10 .2 )mmHg降为治疗后的 ( 12 8.1± 15 .5 ) / ( 81.6±8.3 )mmHg。结论 :洛汀新对混合性高血压、单纯性收缩压升高及单纯性舒张压升高均有明显的降压效果 ,不良反应轻微 。 Objective:To study the effect and security of Lotensin in treatment of hypertension.Methods:58 cases of primary hypertension were treated with Lotensin for 8 weeks. Results: After treatment, the pressure declined from 143.7±18.7/92.2±10.2 to 128.1±5.5/81.6±8.3 mmHg.The total efficiency was 89.66% and the significant efficiency was 75.86%. Conclusion: Lotensin has significant pressure lowered effects for compound hypertension group,simple high systolic pressure group and simple high diastolic pressure group and has feeble harmful reaction. It is fit for clinical application.
出处 《实用临床医学(江西)》 CAS 2002年第2期41-42,共2页 Practical Clinical Medicine
  • 相关文献

参考文献3

二级参考文献30

  • 1[1]Weber KT, Brilla CG, Janicki TS. [J]. Cardiovasc Res, 1993,27:341-348.
  • 2[2]Weber KT, Sun Y, Tyagi SC, et al. [J]. Mol Cell Cardiol, 1994,26:279-292.
  • 3[3]Brilla CG, Janicki JS, Weber KT. [J]. Circulation,1991, 83:1771-1779.
  • 4[4]Brilla CG, Matsubara L, Weber KT. [J]. Hypertension, 1996,28:269-275.
  • 5[5]Zhu YC, Zhu YZ, Heidi Z, et al. [J]. Diabetes,1996,45 (Suppl 1 ): s59- s65.
  • 6[6]Waeber B, Brumer HR. [J]. J Cardiovasc Pharmacol,1996, 27(Suppl 2) :s36-s40.
  • 7[7]Pick R, Janicki JS, Weber KT. [J]. Am J Pathol,1989,135:771-781.
  • 8[8]Conrad CH, Brooks WW, Hayes JA, et al. [J]. Circulation, 1995, 91:161-170.
  • 9[9]Brilla CG, Zhou G, Matsubara L, et al. [J]. J Moll Cell Cardiol, 1994, 26:809-820.
  • 10[10]Brilla CG, Tan LB, Pick R, et al. [J]. Circ Res,1990, 67:1355-1364.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部